tiprankstipranks
Trending News
More News >

GoodRx price target lowered to $4 from $4.75 at BofA

BofA analyst Allen Lutz lowered the firm’s price target on GoodRx (GDRX) to $4 from $4.75 and keeps an Underperform rating on the shares. GoodRx reported “a mixed, but generally good headline quarter,” beating on both revenue and EBITDA, the analyst tells investors. However, the firm lowered its price target ahead of the earnings call as it lowered its calendar year 2025 EBITDA multiple to reflect lower top-line momentum.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue